Genentech plans new $750 Million expansion project in Hillsboro, Oregon

Hillsboro, Oregon — According to state and local development sources, Genentech plans to invest $750 Million to build out space in Hillsboro. The company is creating 250 new jobs at this facility. The company plans to occupy the new space at 4625 NE Brookwood Pkwy in Hillsboro, on or about January 1, 2028.

According to the company website, Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. Genentech became a member of the Roche Group in March of 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech Research and Early Development operates as a separate business unit within Roche.

To learn more, visit http://www.gene.com/

Company Contact:
Genentech
1 Dna Way
South San Francisco, CA94080
Phone: 650-225-1000
LinkedIn Link: https://www.linkedin.com/company/genentech/

SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.